Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytes. [electronic resource] by
- Lindley, Celeste
- Hamilton, Geraldine
- McCune, Jeannine S
- Faucette, Stephanie
- Shord, Stacy S
- Hawke, Roy L
- Wang, Hongbing
- Gilbert, Darryl
- Jolley, Summer
- Yan, Bingfang
- LeCluyse, Edward L
Producer: 20021230
In:
Drug metabolism and disposition: the biological fate of chemicals vol. 30
Availability: No items available.
|
|
11.
|
A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors. [electronic resource] by
- Adjei, Alex A
- LoRusso, Patricia
- Ribas, Antoni
- Sosman, Jeffrey A
- Pavlick, Anna
- Dy, Grace K
- Zhou, Xiaofei
- Gangolli, Esha
- Kneissl, Michelle
- Faucette, Stephanie
- Neuwirth, Rachel
- Bózon, Viviana
Producer: 20171214
In:
Investigational new drugs vol. 35
Availability: No items available.
|
|
12.
|
A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer. [electronic resource] by
- Gillenwater, Heidi H
- McCune, Jeannine S
- Lindley, Celeste
- Faucette, Stephanie
- Shord, Stacy
- Donahue, Angela
- Socinski, Mark A
- Stewart, Clinton F
- Zamboni, William C
- Kirstein, Mark N
- Moore, Dominic
Producer: 20051122
In:
Cancer investigation vol. 23
Availability: No items available.
|